You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

34 search results for: guidelines

IRS-ISIAN 2024 | Guideline Definitions of Control in CRSwNP
expert video

IRS-ISIAN 2024 | Guideline Definitions of Control in CRSwNP

Rhinology
Prof. Peter Hellings explores the concept of disease control in CRSwNP.
View more
Pediatric Asthma Patient Case Tool: Ash
interactivity

Pediatric Asthma Patient Case Tool: Ash

Pulmonology
Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients
View more
Partnering With Patients: Scores That Matter in CRSwNP
interactivity

Partnering With Patients: Scores That Matter in CRSwNP

Rhinology
Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life
View more
Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case
interactivity

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Gastroenterology
Experience a pediatric patient's journey from infancy to adolescence with guideline-based learnings on EoE diagnosis, treatment, and long-term care.
View more
Defining Mechanisms of Anosmia in CRSwNP
videoanimation

Defining Mechanisms of Anosmia in CRSwNP

Rhinology
Prof. Wytske Fokkens examines what is known and what else should be explored to understand the mechanisms of anosmia in patients with CRSwNP.
View more
Understanding Disease Mechanisms
expert video

Understanding Disease Mechanisms

Dermatology
Watch Dr. Armstrong explain the role type 2 inflammation plays in atopic dermatitis and hand and foot dermatitis.
View more
How Can FeNO Measurement Improve Severe Asthma Management?
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

Pulmonology
Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.
View more
IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP
expert video

IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP

Rhinology
Prof. Peter Hellings highlights the EPOS/EUFOREA 2024 definition of remission and calls for an elevation of treatment goals in CRSwNP.
View more
ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Pulmonology
Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ADVENT On Air | First-hand Experience: Practical Insights On the Diagnosis and Assessment of Atopic Dermatitis of the Hands and Feet
Podcast

ADVENT On Air | First-hand Experience: Practical Insights On the Diagnosis and Assessment of Atopic Dermatitis of the Hands and Feet

Dermatology
This podcast episode discusses best practices for the diagnosis of atopic dermatitis of the hands and feet
View more
ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?
Podcast

ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?

Dermatology
This podcast episode looks at the epidemiology, clinical presentation and classification of atopic dermatitis of the hand and feet and the impact it has on patients' quality of life.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region